NCT06961266View on ClinicalTrials.gov

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

PHASE1RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Narcolepsy
Interventions
DRUG

JZP441

Administered orally

DRUG

Matching Placebo

Administered orally

Trial Locations (4)

29201

RECRUITING

Clinical Trial Site, Columbia

30328

RECRUITING

Clinical Trial Site, Atlanta

45245

RECRUITING

Clinical Trial Site, Cincinnati

78731

RECRUITING

Clinical Trial Site, Austin

Sponsors
All Listed Sponsors
collaborator

Jazz Pharmaceuticals Ireland Limited

INDUSTRY

lead

Jazz Pharmaceuticals

INDUSTRY